Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences.

Maturitas

Carrera PM, Ormond M.
PMID: 25981825
Maturitas. 2015 Sep;82(1):94-9. doi: 10.1016/j.maturitas.2015.04.008. Epub 2015 Apr 23.

Both at the individual and health system levels, the burden of complex illnesses associated with and which rise in mid- to later life, such as cancer, is expected to increase further. The advent of personalized medicine, or the use...

Cite
Carrera PM, Ormond M. Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences. Maturitas. 2015;82(1):94-9doi: 10.1016/j.maturitas.2015.04.008.
Carrera, P. M., & Ormond, M. (2015). Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences. Maturitas, 82(1), 94-9. https://doi.org/10.1016/j.maturitas.2015.04.008
Carrera, Pricivel M, and Ormond, Meghann. "Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences." Maturitas vol. 82,1 (2015): 94-9. doi: https://doi.org/10.1016/j.maturitas.2015.04.008
Carrera PM, Ormond M. Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences. Maturitas. 2015 Sep;82(1):94-9. doi: 10.1016/j.maturitas.2015.04.008. Epub 2015 Apr 23. PMID: 25981825.
Copy Download .nbib Format: NLM
Chairman's introduction. Lung cancer.

European journal of cancer (Oxford, England : 1990)

Van Houtte P.
PMID: 11888006
Eur J Cancer. 2001 Oct;37:S61. doi: 10.1016/s0959-8049(01)80007-1.

No abstract available.

Cite
Van Houtte P. Chairman's introduction. Lung cancer. Eur J Cancer. 2001;37:S61doi: 10.1016/s0959-8049(01)80007-1.
Van Houtte, P. (2001). Chairman's introduction. Lung cancer. European journal of cancer (Oxford, England : 1990), 37S61. https://doi.org/10.1016/s0959-8049(01)80007-1
Van Houtte, P. "Chairman's introduction. Lung cancer." European journal of cancer (Oxford, England : 1990) vol. 37 (2001): S61. doi: https://doi.org/10.1016/s0959-8049(01)80007-1
Van Houtte P. Chairman's introduction. Lung cancer. Eur J Cancer. 2001 Oct;37:S61. doi: 10.1016/s0959-8049(01)80007-1. PMID: 11888006.
Copy Download .nbib Format: NLM
[Lung cancer: molecular bases].

Pathologica

Marchetti A.
PMID: 16440635
Pathologica. 2005 Aug;97(4):170.

No abstract available.

Cite
Marchetti A. Cancro polmonare: basi molecolari. [Lung cancer: molecular bases]. Pathologica. 2005;97(4):170
Marchetti, A. (2005). Cancro polmonare: basi molecolari. [Lung cancer: molecular bases]. Pathologica, 97(4), 170.
Marchetti, A. "Cancro polmonare: basi molecolari." [Lung cancer: molecular bases]. Pathologica vol. 97,4 (2005): 170.
Marchetti A. Cancro polmonare: basi molecolari. [Lung cancer: molecular bases]. Pathologica. 2005 Aug;97(4):170. Italian. PMID: 16440635.
Copy Download .nbib Format: NLM
[Lung cancer--histopathology and molecular pathogenesis].

Arkhiv patologii

Matsko DE, Zhelbunova EA, Imianitov EN.
PMID: 18314543
Arkh Patol. 2007;2-24.

No abstract available.

Cite
Matsko DE, Zhelbunova EA, Imianitov EN. [Lung cancer--histopathology and molecular pathogenesis]. Arkh Patol. 2007;2-24
Matsko, D. E., Zhelbunova, E. A., & Imianitov, E. N. (2007). [Lung cancer--histopathology and molecular pathogenesis]. Arkhiv patologii, 2-24.
Matsko, Dmitriĭ Evgen'evich, et al. "[Lung cancer--histopathology and molecular pathogenesis]." Arkhiv patologii vol. (2007): 2-24.
Matsko DE, Zhelbunova EA, Imianitov EN. [Lung cancer--histopathology and molecular pathogenesis]. Arkh Patol. 2007;2-24. Russian. PMID: 18314543.
Copy Download .nbib Format: NLM
Combined analysis with copy number variation identifies risk loci in lung cancer.

BioMed research international

Li X, Chen X, Hu G, Liu Y, Zhang Z, Wang P, Zhou Y, Yi X, Zhang J, Zhu Y, Wei Z, Yuan F, Zhao G, Zhu J, Hu L, Kong X.
PMID: 25093167
Biomed Res Int. 2014;2014:469103. doi: 10.1155/2014/469103. Epub 2014 Jul 01.

BACKGROUND: Lung cancer is the most important cause of cancer mortality worldwide, but the underlying mechanisms of this disease are not fully understood. Copy number variations (CNVs) are promising genetic variations to study because of their potential effects on...

Cite
Li X, Chen X, Hu G, et al. Combined analysis with copy number variation identifies risk loci in lung cancer. Biomed Res Int. 2014;2014:469103doi: 10.1155/2014/469103.
Li, X., Chen, X., Hu, G., Liu, Y., Zhang, Z., Wang, P., Zhou, Y., Yi, X., Zhang, J., Zhu, Y., Wei, Z., Yuan, F., Zhao, G., Zhu, J., Hu, L., & Kong, X. (2014). Combined analysis with copy number variation identifies risk loci in lung cancer. BioMed research international, 2014469103. https://doi.org/10.1155/2014/469103
Li, Xinlei, et al. "Combined analysis with copy number variation identifies risk loci in lung cancer." BioMed research international vol. 2014 (2014): 469103. doi: https://doi.org/10.1155/2014/469103
Li X, Chen X, Hu G, Liu Y, Zhang Z, Wang P, Zhou Y, Yi X, Zhang J, Zhu Y, Wei Z, Yuan F, Zhao G, Zhu J, Hu L, Kong X. Combined analysis with copy number variation identifies risk loci in lung cancer. Biomed Res Int. 2014;2014:469103. doi: 10.1155/2014/469103. Epub 2014 Jul 01. PMID: 25093167; PMCID: PMC4100386.
Copy Download .nbib Format: NLM
[Reciprocal regulation between microRNAs and DNA methylation in lung cancer].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Xie D, Chen XF.
PMID: 21781522
Zhonghua Jie He He Hu Xi Za Zhi. 2011 Jun;34(6):462-3.

No abstract available.

Cite
Xie D, Chen XF. [Reciprocal regulation between microRNAs and DNA methylation in lung cancer]. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34(6):462-3
Xie, D., & Chen, X. F. (2011). [Reciprocal regulation between microRNAs and DNA methylation in lung cancer]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 34(6), 462-3.
Xie, Dong, and Chen, Xiao-feng. "[Reciprocal regulation between microRNAs and DNA methylation in lung cancer]." Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases vol. 34,6 (2011): 462-3.
Xie D, Chen XF. [Reciprocal regulation between microRNAs and DNA methylation in lung cancer]. Zhonghua Jie He He Hu Xi Za Zhi. 2011 Jun;34(6):462-3. Chinese. PMID: 21781522.
Copy Download .nbib Format: NLM
The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

El-Zein RA, Lopez MS, D'Amelio AM, Liu M, Munden RF, Christiani D, Su L, Tejera-Alveraz P, Zhai R, Spitz MR, Etzel CJ.
PMID: 25172871
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2462-70. doi: 10.1158/1055-9965.EPI-14-0462. Epub 2014 Aug 29.

BACKGROUND: There is an urgent need to improve lung cancer outcome by identifying and validating markers of risk. We previously reported that the cytokinesis-blocked micronucleus assay (CBMN) is a strong predictor of lung cancer risk. Here, we validate our...

Cite
El-Zein RA, Lopez MS, D'Amelio AM, et al. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2462-70doi: 10.1158/1055-9965.EPI-14-0462.
El-Zein, R. A., Lopez, M. S., D'Amelio, A. M., Liu, M., Munden, R. F., Christiani, D., Su, L., Tejera-Alveraz, P., Zhai, R., Spitz, M. R., & Etzel, C. J. (2014). The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 23(11), 2462-70. https://doi.org/10.1158/1055-9965.EPI-14-0462
El-Zein, Randa A, et al. "The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 23,11 (2014): 2462-70. doi: https://doi.org/10.1158/1055-9965.EPI-14-0462
El-Zein RA, Lopez MS, D'Amelio AM, Liu M, Munden RF, Christiani D, Su L, Tejera-Alveraz P, Zhai R, Spitz MR, Etzel CJ. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2462-70. doi: 10.1158/1055-9965.EPI-14-0462. Epub 2014 Aug 29. PMID: 25172871; PMCID: PMC4487661.
Copy Download .nbib Format: NLM
Response to Lee et al.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Feller-Kopman D, Liu S, Geisler BP, DeCamp MM, Pietzsch JB.
PMID: 28838721
J Thorac Oncol. 2017 Sep;12(9):e152-e153. doi: 10.1016/j.jtho.2017.07.002.

No abstract available.

Cite
Feller-Kopman D, Liu S, Geisler BP, et al. Response to Lee et al. J Thorac Oncol. 2017;12(9):e152-e153doi: 10.1016/j.jtho.2017.07.002.
Feller-Kopman, D., Liu, S., Geisler, B. P., DeCamp, M. M., & Pietzsch, J. B. (2017). Response to Lee et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 12(9), e152-e153. https://doi.org/10.1016/j.jtho.2017.07.002
Feller-Kopman, David, et al. "Response to Lee et al." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 12,9 (2017): e152-e153. doi: https://doi.org/10.1016/j.jtho.2017.07.002
Feller-Kopman D, Liu S, Geisler BP, DeCamp MM, Pietzsch JB. Response to Lee et al. J Thorac Oncol. 2017 Sep;12(9):e152-e153. doi: 10.1016/j.jtho.2017.07.002. PMID: 28838721.
Copy Download .nbib Format: NLM
Lung cancer as a paradigm for precision oncology in solid tumours.

Virchows Archiv : an international journal of pathology

Schallenberg S, Merkelbach-Bruse S, Buettner R.
PMID: 28730537
Virchows Arch. 2017 Aug;471(2):221-233. doi: 10.1007/s00428-017-2183-2. Epub 2017 Jul 20.

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death in the western world. However, the combination of molecular genotyping and subsequent systematic treatment of decoded target structures is a prime example of precision oncology in solid...

Cite
Schallenberg S, Merkelbach-Bruse S, Buettner R. Lung cancer as a paradigm for precision oncology in solid tumours. Virchows Arch. 2017;471(2):221-233doi: 10.1007/s00428-017-2183-2.
Schallenberg, S., Merkelbach-Bruse, S., & Buettner, R. (2017). Lung cancer as a paradigm for precision oncology in solid tumours. Virchows Archiv : an international journal of pathology, 471(2), 221-233. https://doi.org/10.1007/s00428-017-2183-2
Schallenberg, Simon, et al. "Lung cancer as a paradigm for precision oncology in solid tumours." Virchows Archiv : an international journal of pathology vol. 471,2 (2017): 221-233. doi: https://doi.org/10.1007/s00428-017-2183-2
Schallenberg S, Merkelbach-Bruse S, Buettner R. Lung cancer as a paradigm for precision oncology in solid tumours. Virchows Arch. 2017 Aug;471(2):221-233. doi: 10.1007/s00428-017-2183-2. Epub 2017 Jul 20. PMID: 28730537.
Copy Download .nbib Format: NLM
Lung cancer-celebrating progress and acknowledging challenges.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Adjei AA.
PMID: 24128710
J Thorac Oncol. 2013 Nov;8(11):1350-1. doi: 10.1097/JTO.0000000000000008.

No abstract available.

Cite
Adjei AA. Lung cancer-celebrating progress and acknowledging challenges. J Thorac Oncol. 2013;8(11):1350-1doi: 10.1097/JTO.0000000000000008.
Adjei, A. A. (2013). Lung cancer-celebrating progress and acknowledging challenges. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 8(11), 1350-1. https://doi.org/10.1097/JTO.0000000000000008
Adjei, Alex A. "Lung cancer-celebrating progress and acknowledging challenges." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 8,11 (2013): 1350-1. doi: https://doi.org/10.1097/JTO.0000000000000008
Adjei AA. Lung cancer-celebrating progress and acknowledging challenges. J Thorac Oncol. 2013 Nov;8(11):1350-1. doi: 10.1097/JTO.0000000000000008. PMID: 24128710.
Copy Download .nbib Format: NLM
Classifying multiple lung cancers using morphological features: a meta-analysis.

Journal of immunoassay & immunochemistry

Mlika M, Zorgati M, Mezni FE.
PMID: 32579047
J Immunoassay Immunochem. 2020 Sep 02;41(5):817-832. doi: 10.1080/15321819.2020.1779740. Epub 2020 Jun 24.

Multiple lung cancers may be intrapulmonary metastases or multiple primaries. Management and prognosis of both entities are different and make the pathologist's role challenging. In fact, distinguishing both entities may be difficult especially when the tumors present the same...

Cite
Mlika M, Zorgati M, Mezni FE. Classifying multiple lung cancers using morphological features: a meta-analysis. J Immunoassay Immunochem. 2020;41(5):817-832doi: 10.1080/15321819.2020.1779740.
Mlika, M., Zorgati, M., & Mezni, F. E. (2020). Classifying multiple lung cancers using morphological features: a meta-analysis. Journal of immunoassay & immunochemistry, 41(5), 817-832. https://doi.org/10.1080/15321819.2020.1779740
Mlika, Mona, et al. "Classifying multiple lung cancers using morphological features: a meta-analysis." Journal of immunoassay & immunochemistry vol. 41,5 (2020): 817-832. doi: https://doi.org/10.1080/15321819.2020.1779740
Mlika M, Zorgati M, Mezni FE. Classifying multiple lung cancers using morphological features: a meta-analysis. J Immunoassay Immunochem. 2020 Sep 02;41(5):817-832. doi: 10.1080/15321819.2020.1779740. Epub 2020 Jun 24. PMID: 32579047.
Copy Download .nbib Format: NLM
Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk.

International journal of cancer

Dai J, Huang M, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, Rennert G, Fan J, Goodman G, Liu G, Field JK, Grankvist K, Kiemeney LA, Le Marchand L, Schabath MB, Johansson M, Aldrich MC, Johansson M, Caporaso N, Lazarus P, Lam S, Bojesen SE, Arnold S, Landi MT, Risch A, Wichmann HE, Bickeboller H, Brennan P, Shete S, Melander O, Brunnstrom H, Zienolddiny S, Woll P, Stevens V, Hu Z, Shen H.
PMID: 31577861
Int J Cancer. 2020 May 15;146(10):2855-2864. doi: 10.1002/ijc.32698. Epub 2019 Oct 31.

Genome-wide association studies (GWAS) have identified 45 susceptibility loci associated with lung cancer. Only less than SNPs, small insertions and deletions (INDELs) are the second most abundant genetic polymorphisms in the human genome. INDELs are highly associated with multiple...

Cite
Dai J, Huang M, Amos CI, et al. Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. Int J Cancer. 2019;146(10):2855-2864doi: 10.1002/ijc.32698.
Dai, J., Huang, M., Amos, C. I., Hung, R. J., Tardon, A., Andrew, A., Chen, C., Christiani, D. C., Albanes, D., Rennert, G., Fan, J., Goodman, G., Liu, G., Field, J. K., Grankvist, K., Kiemeney, L. A., Le Marchand, L., Schabath, M. B., Johansson, M., Aldrich, M. C., Johansson, M., Caporaso, N., Lazarus, P., Lam, S., Bojesen, S. E., Arnold, S., Landi, M. T., Risch, A., Wichmann, H. E., Bickeboller, H., Brennan, P., Shete, S., Melander, O., Brunnstrom, H., Zienolddiny, S., Woll, P., Stevens, V., Hu, Z., & Shen, H. (2020). Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. International journal of cancer, 146(10), 2855-2864. https://doi.org/10.1002/ijc.32698
Dai, Juncheng, et al. "Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk." International journal of cancer vol. 146,10 (2020): 2855-2864. doi: https://doi.org/10.1002/ijc.32698
Dai J, Huang M, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, Rennert G, Fan J, Goodman G, Liu G, Field JK, Grankvist K, Kiemeney LA, Le Marchand L, Schabath MB, Johansson M, Aldrich MC, Johansson M, Caporaso N, Lazarus P, Lam S, Bojesen SE, Arnold S, Landi MT, Risch A, Wichmann HE, Bickeboller H, Brennan P, Shete S, Melander O, Brunnstrom H, Zienolddiny S, Woll P, Stevens V, Hu Z, Shen H. Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. Int J Cancer. 2020 May 15;146(10):2855-2864. doi: 10.1002/ijc.32698. Epub 2019 Oct 31. PMID: 31577861; PMCID: PMC7101262.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries